Off-label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice
Off-label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice

Off-label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice

Pediatr Allergy Immunol. 2025 Feb;36(2):e70049. doi: 10.1111/pai.70049.

NO ABSTRACT

PMID:39963804 | DOI:10.1111/pai.70049